Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2014
10/23/2014US20140314763 Cross-reactive and bispecific anti-il-17a/f antibodies
10/23/2014US20140314761 Polypeptides having antiviral activity and methods for use thereof
10/23/2014US20140314760 Serine protease molecules and therapies
10/23/2014US20140314756 Method for treating psoriasis
10/23/2014US20140314755 Antibody producing non-human mammals
10/23/2014US20140314754 Humanized Neuraminidase Antibody and Methods of Use Thereof
10/23/2014US20140314749 Compositions and methods for diagnosis and treatment of hepatic cancers
10/23/2014US20140314745 Methods to control protein heterogeneity
10/23/2014US20140314744 Mcam antagonists and methods of treatment
10/23/2014US20140314743 Amino acid sequences directed against il-17a, il-17f and/or il17-a/f and polypeptides comprising the same
10/23/2014US20140314742 Endoglin antibodies
10/23/2014US20140314741 Human Antibody against Interleukin-20 and Treatment for Inflammatory Diseases
10/23/2014US20140314740 Compositions and methods for the prevention or treatment of diabetic complications
10/23/2014US20140314714 Immunopotentiative composition
10/23/2014US20140314711 IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE
10/23/2014US20140314675 Cancer stem cell isolation
10/21/2014US8865881 Delivery of proteins using adeno-associated virus (AAV) vectors
10/21/2014US8865875 Site-specific attachment of drugs or other agents to engineered antibodies with C-terminal extensions
10/21/2014US8865874 Hapten compound and antibody
10/21/2014US8865873 Internalizing human monoclonal antibodies targeting prostate cancer cells in situ
10/21/2014US8865871 Antibodies and kits for immunodetection of epitope tags
10/21/2014US8865870 Anti-CXCR3 antibodies and methods of use thereof
10/21/2014US8865431 Antigen binding domains
10/21/2014US8865430 Fusion polypeptides capable of activating receptors
10/21/2014US8865425 Reagent and reagent kit for measurement of FDP, and measurement method
10/21/2014US8865424 Anti-FDP monoclonal antibody, FDP measurement reagent and reagent kit using same, and FDP measurement method
10/21/2014US8865414 Detection conjugate and method for analysis
10/21/2014US8865398 Combination hepatitis C virus antigen and antibody detection method
10/21/2014US8865179 Aptameric IgE peptides in a protein scaffold as an allergy vaccine
10/21/2014US8865178 Compositions and methods for wound healing
10/21/2014US8865176 Methods and compositions for generating bioactive assemblies of increased complexity and uses
10/21/2014US8865175 Increasing anti-IL-1α antibodies in a subject
10/21/2014US8865174 Methods of treatment using human antibodies that bind IL-12
10/21/2014US8865173 Treatments for pancreatic cancer metastases
10/21/2014US8865171 Soluble forms of Hendra and Nipah virus G glycoprotein
10/21/2014US8865170 Anti-human CCR7 antibody, hybridoma, nucleic acid, vector, cell, pharmaceutical composition, and antibody-immobilized carrier
10/21/2014US8865169 Methods and systems for multi-antibody therapies
10/21/2014US8865167 Neutralising antibody molecules having specificity for human IL-17
10/21/2014US8865166 Antibodies to IL-17A and uses thereof
10/21/2014US8865165 Monoclonal antibody against group 2 allergen of Dermatophagoides pteronyssiuns, hybridoma cell line producing thereof, strip, kit and method using said monoclonal antibody for dust mite assay
10/21/2014US8865163 Pharmaceutical compositions and methods of treatment
10/21/2014US8865162 Monoclonal antibodies against HPV proteins
10/21/2014US8865159 Treatment of tumors by ablating bone marrow-derived endothelial progenitor cells
10/16/2014US20140309405 Method of producing heterogeneous protein
10/16/2014US20140309404 BMP-6 Antibodies
10/16/2014US20140309403 Novel protein purification methods
10/16/2014US20140309292 Mutations of Histone Proteins Associated with Proliferative Disorders
10/16/2014US20140309163 Fibronectin based scaffold domain proteins that bind to myostatin
10/16/2014US20140308703 Mammalian Cell Lines for Increasing Longevity and Protein Yield from a Cell Culture
10/16/2014US20140308685 Antibody capable of binding to specific region of periostin, and method for measuring periostin using same
10/16/2014US20140308657 Serine protease inhibitor kazal antibodies
10/16/2014US20140308302 Anti-5t4 antibodies and uses thereof
10/16/2014US20140308301 Cd44 monoclonal antibody for the treatment of b-cell chronic lymphocytic leukemia and other hematological malignancies
10/16/2014US20140308298 Diagnostic and Treatment of an Androgen-Independent Prostate Cancer
10/16/2014US20140308297 Stem Cell Fusion Model of Carcinogenesis
10/16/2014US20140308295 Adult Stem Cells/Progenitor Cells and Stem Cell Proteins for Treatment of Eye Injuries and Diseases
10/16/2014US20140308294 Anti-IL-1R1 Inhibitors For Use in Cancer
10/16/2014US20140308293 Reconstitution method for high concentration dry protein formulations
10/16/2014US20140308292 Family of pain producing substances and methods to produce novel analgesic drugs
10/16/2014US20140308291 Immunogenic Composition Comprising Panton-Valentine Leukocidin (PVL) Derived Polypeptides
10/16/2014US20140308290 Methods for treating visceral pain by administering antagonist antibodies directed against calcitonin gene-related peptide
10/16/2014US20140308289 Extracellular histones as biomarkers for prognosis and molecular targets for therapy
10/16/2014US20140308288 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
10/16/2014US20140308287 Sur-binding proteins
10/16/2014US20140308286 Dual variable domain immunoglobulins and uses thereof
10/16/2014US20140308285 Heterodimeric bispecific antibodies
10/16/2014US20140308283 Pharmaceutical composition for treatment and/or prevention of pancreatic cancer
10/16/2014US20140308281 Antibodies directed against the alpha chain of il7 receptor - their use for the preparation of drug candidates
10/16/2014US20140308280 Factor VIII Polypeptide Formulations
10/16/2014US20140308279 Anti-ErbB3 Antibodies and Uses Thereof
10/16/2014US20140308278 Class I Anti-CEA Antibodies and Uses Thereof
10/16/2014US20140308277 Pertuzumab variants and evaluation thereof
10/16/2014US20140308276 Anti-ox40 antibodies and methods of using the same
10/16/2014US20140308273 Cell culture media and methods of antibody production
10/16/2014US20140308272 Treatment of prion protein related diseases
10/16/2014US20140308271 Antibodies that bind to tl1a and their uses
10/16/2014US20140308270 Method and formulation for reducing aggregation of a macromolecule under physiological conditions
10/16/2014US20140308269 Humanized antibodies
10/16/2014US20140308259 Isolated b7-h4 specific compositions and methods of use thereof
10/16/2014US20140308209 Soluble Mediator
10/16/2014US20140308206 Fc receptor binding proteins
10/14/2014US8860979 Deletion of unwanted reply messages in e-mail printing
10/14/2014US8859854 Method for modifying plant morphology, biochemistry and physiology
10/14/2014US8859741 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)
10/14/2014US8859740 Anti-infective binding proteins that bind AIP2
10/14/2014US8859739 Anti-huTNFR1 antibody and methods of use thereof for treatment
10/14/2014US8859737 Anti-HER3 antibodies and uses thereof
10/14/2014US8859736 Monoclonal antibodies that inhibit the wnt signaling pathway and methods of production and use thereof
10/14/2014US8859726 Affinity chromatography matrix
10/14/2014US8859725 Healthy kidney biomarkers
10/14/2014US8859723 Peptidomimetic macrocycles
10/14/2014US8859509 Chimeric small molecules for the recruitment of antibodies to cancer cells
10/14/2014US8859501 Protofibril-binding antibodies and their use in thereapeutic and diagnostic methods for parkinson's disease, dementia with lewy bodies and other alpha-synucleinopathies
10/14/2014US8859495 Methods for stimulating or enhancing proliferation of non-tumorous cells expressing MUC1 receptors
10/14/2014US8859467 Simultaneous, integrated selection and evolution of antibody/protein performance and expression in production hosts
10/14/2014US8859284 Delivery of nanoparticles to neurons
10/14/2014US8859278 Fully human hybridoma fusion partner cell lines
10/14/2014US8859234 Fusion constructs and use of same to produce antibodies with increased Fc receptor binding affinity and effector function
10/14/2014US8859233 Method for immunizing an avian species
10/14/2014US8859223 Compositions and methods for imaging beta-secretase activity in living cells and organisms
1 ... 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 ... 1494